191 related articles for article (PubMed ID: 35735997)
1. Novel Engineered SARS-CoV-2 HR1 Trimer Exhibits Improved Potency and Broad-Spectrum Activity against SARS-CoV-2 and Its Variants.
Bi W; Chen G; Dang B
J Virol; 2022 Jul; 96(13):e0068122. PubMed ID: 35735997
[TBL] [Abstract][Full Text] [Related]
2. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
3. Repurposing fusion inhibitor peptide against SARS-CoV-2.
Efaz FM; Islam S; Talukder SA; Akter S; Tashrif MZ; Ali MA; Sufian MA; Parves MR; Islam MJ; Halim MA
J Comput Chem; 2021 Dec; 42(32):2283-2293. PubMed ID: 34591335
[TBL] [Abstract][Full Text] [Related]
4. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
Yang K; Wang C; Kreutzberger AJB; Ojha R; Kuivanen S; Couoh-Cardel S; Muratcioglu S; Eisen TJ; White KI; Held RG; Subramanian S; Marcus K; Pfuetzner RA; Esquivies L; Doyle CA; Kuriyan J; Vapalahti O; Balistreri G; Kirchhausen T; Brunger AT
Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2210990119. PubMed ID: 36122200
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
Sun Y; Zhang H; Shi J; Zhang Z; Gong R
Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
[TBL] [Abstract][Full Text] [Related]
6. In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2.
Ling R; Dai Y; Huang B; Huang W; Yu J; Lu X; Jiang Y
Peptides; 2020 Aug; 130():170328. PubMed ID: 32380200
[TBL] [Abstract][Full Text] [Related]
7. Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins.
Polo-Megías D; Cano-Muñoz M; Berruezo AG; Laumond G; Moog C; Conejero-Lara F
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555153
[TBL] [Abstract][Full Text] [Related]
8. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion.
Xia S; Liu M; Wang C; Xu W; Lan Q; Feng S; Qi F; Bao L; Du L; Liu S; Qin C; Sun F; Shi Z; Zhu Y; Jiang S; Lu L
Cell Res; 2020 Apr; 30(4):343-355. PubMed ID: 32231345
[TBL] [Abstract][Full Text] [Related]
10. Kaempferol inhibits SARS-CoV-2 invasion by impairing heptad repeats-mediated viral fusion.
Gao J; Cao C; Shi M; Hong S; Guo S; Li J; Liang T; Song P; Xu R; Li N
Phytomedicine; 2023 Sep; 118():154942. PubMed ID: 37421767
[TBL] [Abstract][Full Text] [Related]
11. Designing Self-Inhibitory fusion peptide analogous to viral spike protein against novel severe acute respiratory syndrome (SARS-CoV-2).
Singh I; Singh S; Ojha KK; Yadav NS
J Biomol Struct Dyn; 2022; 40(21):11357-11372. PubMed ID: 34379031
[TBL] [Abstract][Full Text] [Related]
12. A Five-Helix-Based SARS-CoV-2 Fusion Inhibitor Targeting Heptad Repeat 2 Domain against SARS-CoV-2 and Its Variants of Concern.
Xing L; Xu X; Xu W; Liu Z; Shen X; Zhou J; Xu L; Pu J; Yang C; Huang Y; Lu L; Jiang S; Liu S
Viruses; 2022 Mar; 14(3):. PubMed ID: 35337003
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
[TBL] [Abstract][Full Text] [Related]
14. Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines.
Guo L; Lin S; Chen Z; Cao Y; He B; Lu G
Signal Transduct Target Ther; 2023 May; 8(1):197. PubMed ID: 37164987
[TBL] [Abstract][Full Text] [Related]
15. An enhanced broad-spectrum peptide inhibits Omicron variants in vivo.
Bi W; Tang K; Chen G; Xie Y; Polizzi NF; DeGrado WF; Yuan S; Dang B
Cell Rep Med; 2024 Feb; 5(2):101418. PubMed ID: 38340726
[TBL] [Abstract][Full Text] [Related]
16. An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen.
Wang X; Sun L; Liu Z; Xing L; Zhu Y; Xu W; Xia S; Lu L; Jiang S
Emerg Microbes Infect; 2023 Dec; 12(2):2244084. PubMed ID: 37534910
[TBL] [Abstract][Full Text] [Related]
17. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.
Xia S; Lan Q; Pu J; Wang C; Liu Z; Xu W; Wang Q; Liu H; Jiang S; Lu L
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646495
[TBL] [Abstract][Full Text] [Related]
18. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
Channappanavar R; Lu L; Xia S; Du L; Meyerholz DK; Perlman S; Jiang S
J Infect Dis; 2015 Dec; 212(12):1894-903. PubMed ID: 26164863
[TBL] [Abstract][Full Text] [Related]
19. Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies.
Li J; Li Q; Xia S; Tu J; Zheng L; Wang Q; Jiang S; Wang C
Bioorg Med Chem Lett; 2024 Jan; 97():129569. PubMed ID: 38008340
[TBL] [Abstract][Full Text] [Related]
20. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the pre-hairpin intermediate of the spike protein.
Yang K; Wang C; Kreutzberger AJB; Ojha R; Kuivanen S; Couoh-Cardel S; Muratcioglu S; Eisen TJ; White KI; Held RG; Subramanian S; Marcus K; Pfuetzner RA; Esquivies L; Doyle CA; Kuriyan J; Vapalahti O; Balistreri G; Kirchhausen T; Brunger AT
bioRxiv; 2022 Aug; ():. PubMed ID: 35982670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
